We are live on ! Find out more
FFA

Farther Finance Advisors Portfolio holdings

AUM $12.8B
1-Year Est. Return 26.53%
This Fund
S&P 500
This Quarter Est. Return
+0.63%
1 Year Est. Return
+26.53%
3 Year Est. Return
+74.11%
5 Year Est. Return
10 Year Est. Return
AUM
$2.77B
AUM Growth
+$100M
Cap. Flow
+$107M
Cap. Flow %
3.85%
Top 10 Hldgs %
25.37%
Holding
4,242
New
232
Increased
1,281
Reduced
1,614
Closed
226

Sector Composition

Rank Sector Weight
1 Technology 10.41%
2 Financials 4.58%
3 Consumer Discretionary 3.66%
4 Healthcare 3.06%
5 Industrials 2.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSBI icon
3926
Midland States Bancorp
MSBI
$695M
$24 ﹤0.01%
1
ODP
3927
DELISTED
ODP
ODP
$23 ﹤0.01%
1
-140
-99% -$3.9K
SGHT icon
3928
Sight Sciences
SGHT
$412M
$22 ﹤0.01%
6
-18
-75% -$82
BANX
3929
ArrowMark Financial
BANX
$199M
$21 ﹤0.01%
+1
New +$21
QTRX icon
3930
Quanterix
QTRX
$190M
$21 ﹤0.01%
2
-5
-71% -$61
QTTB icon
3931
Q32 Bio
QTTB
$464M
$21 ﹤0.01%
+6
New +$189
SPLB icon
3932
State Street SPDR Portfolio Long Term Corporate Bond ETF
SPLB
$1.19B
$20 ﹤0.01%
1
ONT
3933
Onterris Inc
ONT
$580M
$19 ﹤0.01%
1
-10
-91% -$210
VRDN icon
3934
Viridian Therapeutics
VRDN
$2.67B
$19 ﹤0.01%
1
CARE icon
3935
Carter Bankshares
CARE
$731M
$18 ﹤0.01%
1
GTBP icon
3936
GT Biopharma
GTBP
$11.5M
$18 ﹤0.01%
+6
New +$16
EGRX
3937
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$18 ﹤0.01%
35
-29
-45% -$83
ACB
3938
Aurora Cannabis
ACB
$185M
$17 ﹤0.01%
4
-6
-60% -$29
IEP icon
3939
Icahn Enterprises
IEP
$5.3B
$17 ﹤0.01%
2
STRO icon
3940
Sutro Biopharma
STRO
$421M
$17 ﹤0.01%
1
ACCD
3941
DELISTED
Accolade Inc
ACCD
$17 ﹤0.01%
5
-5
-50% -$18
AMPX.WS icon
3942
Amprius Technologies Warrants
AMPX.WS
$556M
$16 ﹤0.01%
46
+44
+2,200% +$9
KROS icon
3943
Keros Therapeutics
KROS
$221M
$16 ﹤0.01%
1
-1
-50% -$52
YCBD icon
3944
cbdMD
YCBD
$5.93M
$16 ﹤0.01%
5
DTIL icon
3945
Precision BioSciences
DTIL
$207M
$15 ﹤0.01%
+4
New +$29
IBRX icon
3946
ImmunityBio
IBRX
$8.1B
$15 ﹤0.01%
6
+5
+500% +$21
INBX icon
3947
Inhibrx
INBX
$1.3B
$15 ﹤0.01%
1
-1
-50% -$15
LCNB icon
3948
LCNB Corp
LCNB
$283M
$15 ﹤0.01%
1
PLBY icon
3949
Playboy Inc
PLBY
$141M
$15 ﹤0.01%
+10
New +$12
RCUS icon
3950
Arcus Biosciences
RCUS
$3.64B
$15 ﹤0.01%
1

Similar funds

Farther Finance Advisors's Q4 2024 Portfolio in Review

As of Q4 2024, Farther Finance Advisors held 4,242 positions worth $2.77B, up 3.7% from $2.67B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Farther Finance Advisors deployed $107M of net new capital in Q4 2024, opening 232 new positions and adding to 1,281 existing holdings. Its largest new stake was FT Vest Fund of Buffer ETFs: 346,336 shares worth $10.6M.

By sector, the portfolio is most concentrated in Technology at 10% of assets, down from 13% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was NVIDIA, an estimated $72.8M trimmed.

  • Farther Finance Advisors's largest Q4 2024 buy was FT Vest Fund of Buffer ETFs: 346,336 shares worth $10.6M.
  • Farther Finance Advisors added most to iShares 0-3 Month Treasury Bond ETF in Q4 2024, an estimated $14.8M increase.
  • Farther Finance Advisors's biggest Q4 2024 reduction was NVIDIA, cutting an estimated $72.8M.
  • Farther Finance Advisors fully exited Vanguard Morningstar Mega Cap ETF in Q4 2024, selling an estimated $7.28M.
  • Farther Finance Advisors's ten largest holdings make up 25% of its $2.77B portfolio in Q4 2024.
  • Farther Finance Advisors opened 232 new positions and closed 226 in Q4 2024.
  • Farther Finance Advisors's portfolio value rose 3.7% quarter-over-quarter to $2.77B.

Based on Farther Finance Advisors's 13F filing for Q4 2024, filed 10 Feb 2025.